Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer
Citation
Bonomi , P D , Gandara , D , Hirsch , F R , Kerr , K M , Obasaju , C , Paz-Ares , L , Bellomo , C , Bradley , J D , Bunn , P A , Culligan , M , Jett , J R , Kim , E S , Langer , C J , Natale , R B , Novello , S , Pérol , M , Ramalingam , S S , Reck , M , Reynolds , C H , Smit , E F , Socinski , M A , Spigel , D R , Vansteenkiste , J F , Wakelee , H & Thatcher , N 2018 , ' Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer ' , Annals of Oncology , vol. 29 , no. 8 , pp. 1701-1709 . https://doi.org/10.1093/annonc/mdy196
URI
http://hdl.handle.net/2164/11465http://www.scopus.com/inward/record.url?scp=85055507014&partnerID=8YFLogxK
Rights
C The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com